Tennessee Clinical and Translational Science Institute (TN-CTSI), established by the University of Tennessee Health Science Center, aims to improve the health of Tennesseans and underserved populations in the South by providing education and training, fostering interdisciplinary teams, improving quality and efficiency, and engaging community stakeholders and partners in meaningful collaboration. TN-CTSI is designed to be a catalyst for an integrated research and training environment for clinical and translational research in order to improve efficiency and quality across the translational spectrum.


Catalyze the development of methods and technologies that lead to more efficient translation of scientific discoveries into interventions that improve human health across the translational research spectrum, from basic science to population science.


Trains faculty, staff, and students in interdisciplinary team science, clinical trials, informatics, regulatory science, and population science.


Fosters the development of collaborative interdisciplinary teams by providing research support infrastructure while constantly tracking metrics to improve quality, safety, and efficiency in clinical and translational research.


In 2018, UTHSC formed the Tennessee Clinical and Translational Science Institute (TN-CTSI) to catalyze an integrated and interdisciplinary statewide research and training environment for clinical and translational research aimed at improving the efficiency and quality across the translational spectrum.

In Summer 2018, TN-CTSI joined with the Tulane University Translational Science Institute and the Mississippi Clinical Research and Trials Center to form the Delta Clinical and Translational Science Consortium (DCTSC). The DCTSC is a unique partnership of three universities in the Mississippi Delta Region: The University of Tennessee Health Science Center and Tulane University form a Hub, and the University of Mississippi Medical Center joins the Consortium as a collaborating institution. The vision of the DCTSC is to “promote and support high-quality, interdisciplinary, team-based clinical and translational research aimed at improving health outcomes and eliminating health disparities across the entire lifespan in the Mississippi Delta region – particularly in rural areas and for underserved populations.”

The DCTSC was established based on our common objectives and challenges, an extensive history of collaboration, complementary expertise and experience of faculty and staff, strengths of each institution’s research infrastructures, and geographic locations within the Mississippi Delta region where poverty and health disparities are disproportionally affecting our populations. This multi-institutional Consortium allows the three institutions to complement one another and work together to achieve our common goals of improving health outcomes and eliminating health disparities through rigorous research, translation of discoveries to clinical applications, and implementation of the best practice and public health policy. The DCTSC was designed to bring our individual strengths together to tackle common challenges in our region while mitigating our individual limitations in order to conduct novel research across the translational research spectrum (T0-T4). The DCTSC will focus on rural and underserved populations, addressing health disparities to uncover interrelationships of disease phenotypes with genomics, health-related behaviors, environmental exposures, social factors, and healthcare access and quality that affects health across the full lifespan and will target the most prevalent diseases in the populations of Tennessee, Mississippi, and Louisiana.

Our Partners

Since beginning as a medical college in 1834, Tulane University has grown into one of the most well-respected research universities in the country. Today, there are nearly 1,200 full-time faculty and 2,900 staff at Tulane which enrolls 13,200 students from more than 85 countries, including 8,500 undergraduates and 4,700 graduate/professional students. Tulane University is one of just 62 members of the Association of American Universities, an elite group of top-ranked research institutions. The faculty competed successfully for peer-reviewed grants with external research funds totaling $160 million in the past fiscal year. Tulane University established the Tulane University Translational Science Institute in 2016 to promote and increase clinical, translational, and implementation research that has a direct impact on patient care and disease prevention. This objective is being achieved by developing successful independent investigators engaged in clinical, translational, and implementation research; facilitating collaboration among basic, clinical, and population scientists to conduct multidisciplinary research and team science; and building and expanding the clinical and community-based research infrastructure at Tulane University and in Louisiana.
The University of Mississippi Medical Center (UMMC) is composed of seven separate schools: Medicine, Dentistry, Nursing, Health Related Professions, Pharmacy, Population Health, and Graduate Studies in the Health Sciences. It offers programs that lead to MD, PhD, DMD, DNS, DPT, MS, and nursing degrees. UMMC, as part of the University of Mississippi, is among a distinguished group of 115 institutions including Harvard, MIT and Johns Hopkins in the “highest research,” or R-1 category of the Carnegie Classification of Institutions of Higher Education. UMMC established the Mississippi Clinical Research and Trials Center to develop a powerful and sustainable research enterprise that focuses on clinical and translational research in Mississippi. The Institute promotes and nurtures team-science by training the next generation of clinical and translational researchers and encouraging career development.